Atara Biotherapeutics Presents Data Demonstrating Safety & Sustained Disability Improvement at 12 Months with ATA188 in Patients with Progressive Multiple Sclerosis in Late-Breaking e-Poster at th
Go back to Atara Biotherapeutics Presents Data Demonstrating Safety & Sustained Disability Improvement at 12 Months with ATA188 in Patients with Progressive Multiple Sclerosis in Late-Breaking e-Poster at th| (NASDAQ: ATRA) | Delayed: 9.91 -0.32 (3.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.23 | 52 Week High | $40.80 | |||
| Open | $10.27 | 52 Week Low | $12.45 | |||
| Day High | $10.43 | P/E | N/A | |||
| Day Low | $9.76 | EPS | $0.00 | |||
| Volume | 68,457 | |||||
